Ranade S - Search Results

1

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Holekamp NM, Campochiaro PA, Chang MA, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C; all Archway Investigators. Holekamp NM, et al. Among authors: ranade s. Ophthalmology. 2022 Mar;129(3):295-307. doi: 10.1016/j.ophtha.2021.09.016. Epub 2021 Sep 29. Ophthalmology. 2022. PMID: 34597713 Free article. Clinical Trial.

2

In-vitro characterization of ranibizumab release from the Port Delivery System.

Yohe S, Maass KF, Horvath J, Rea J, Barteselli G, Ranade SV. Yohe S, et al. Among authors: ranade sv. J Control Release. 2022 May;345:101-107. doi: 10.1016/j.jconrel.2022.03.005. Epub 2022 Mar 4. J Control Release. 2022. PMID: 35248647 Free article.

3

The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery.

Ranade SV, Wieland MR, Tam T, Rea JC, Horvath J, Hieb AR, Jia W, Grace L, Barteselli G, Stewart JM. Ranade SV, et al. Drug Deliv. 2022 Dec;29(1):1326-1334. doi: 10.1080/10717544.2022.2069301. Drug Deliv. 2022. PMID: 35499315 Free PMC article.

4

Virtual Reality Becomes a Reality for Ophthalmologic Surgical Clinical Trials.

Pieramici DJ, Heimann F, Brassard R, Barteselli G, Ranade S. Pieramici DJ, et al. Among authors: ranade s. Transl Vis Sci Technol. 2020 Jun 3;9(7):1. doi: 10.1167/tvst.9.7.1. eCollection 2020 Jun. Transl Vis Sci Technol. 2020. PMID: 32832208 Free PMC article.

5

Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration.

Bantseev V, Horvath J, Barteselli G, Ranade S, Maia M, Yadav DB, Schuetz C, Shelton A, Booler HS. Bantseev V, et al. Among authors: ranade s. Toxicol Pathol. 2021 Apr;49(3):663-672. doi: 10.1177/0192623320968079. Epub 2020 Nov 18. Toxicol Pathol. 2021. PMID: 33205714

6

A custom virtual reality training solution for ophthalmologic surgical clinical trials.

Heimann F, Barteselli G, Brand A, Dingeldey A, Godard L, Hochstetter H, Schneider M, Rothkegel A, Wagner C, Horvath J, Ranade S. Heimann F, et al. Among authors: ranade s. Adv Simul (Lond). 2021 Apr 16;6(1):12. doi: 10.1186/s41077-021-00167-z. Adv Simul (Lond). 2021. PMID: 33863399 Free PMC article.

7

Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent.

Ranade SV, Miller KM, Richard RE, Chan AK, Allen MJ, Helmus MN. Ranade SV, et al. J Biomed Mater Res A. 2004 Dec 15;71(4):625-34. doi: 10.1002/jbm.a.30188. J Biomed Mater Res A. 2004. PMID: 15514926

8

Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.

Richard RE, Schwarz M, Ranade S, Chan AK, Matyjaszewski K, Sumerlin B. Richard RE, et al. Among authors: ranade s. Biomacromolecules. 2005 Nov-Dec;6(6):3410-8. doi: 10.1021/bm050464v. Biomacromolecules. 2005. PMID: 16283773

9

Styrenic block copolymers for biomaterial and drug delivery applications.

Ranade SV, Richard RE, Helmus MN. Ranade SV, et al. Acta Biomater. 2005 Jan;1(1):137-44. doi: 10.1016/j.actbio.2004.09.004. Acta Biomater. 2005. PMID: 16701787

10

Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.

Sipos L, Som A, Faust R, Richard R, Schwarz M, Ranade S, Boden M, Chan K. Sipos L, et al. Among authors: ranade s. Biomacromolecules. 2005 Sep-Oct;6(5):2570-82. doi: 10.1021/bm050299j. Biomacromolecules. 2005. PMID: 16153094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page